Barmicil Plus Cream
FDA Label NDC 69729-103

13 label sections · Submitted to the FDA by Opmx Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Opmx Llc for the product Barmicil Plus (NDC 69729-103). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor if, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

HYDROCORTISONE USP 1%

Purpose

ANTI-ITCH

Uses

  • FOR THE TEMPORARY RELIEF OF ITCHING ASSOCIATED WITH MINOR SKIN IRRITATIONS, INFLAMMATION, AND RASHES DUE TO:
  •     ECZEMA
  •     SEBORRHEIC DERMATITIS
  •     PSORIASIS   
  •     INSECT BITES
  •     POISON IVY, POISON OAK, AND POISON SUMAC
  •     COSMETICS
  •     JEWELRY
  •     DETERGENTS
  •     SOAPS
  • TEMPORARILY RELIEVES EXTERNAL ANAL AND GENITAL ITCHING
  • OTHER USES OF THIS PRODUC SHOULD BE ONLY UNDER THE ADVICE AND SUPERVISION OF A DOCTOR

Warnings

For external use only.

Other Information

  • STORE AT 20°C TO 25°C (68°F TO 77°F)

Inactive Ingredients

ALOE VERA LEAF EXTRACT, CETOSTEARYL ALCOHOL, GLYCERYL MONOSTEARATE SE, METHYLISOTHIAZOLINONE, PROPYLENE GLYCOL, PURIFIED WATER, STEARIC ACID, TRIETHANOLAMINE, WHITE SOFT PARAFFIN

Package Label.Principal Display Panel

NDC 69729-103-11

Barmicil® plus

with Aloe Vera

1% Hydrocortisone Anti-Itch Cream

Net Wt. 1 oz (28g)

Maximum Strength Cream

  • Inflammation & Redness
  • Skin Irritation & Rashes
  • Insect Bites, Poison Ivy
  • Eczema & Psoriasis
  • Inflamación y Ardor
  • Irritación y Alergia
  • Piquetes de Insectos y Hiedra venenosa
  • Eczema y Psoriasis

* Please review the disclaimer below.